What is the step-by-step procedure for Percutaneous Transvenous Mitral Commissurotomy (PTMC)

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Percutaneous Transvenous Mitral Commissurotomy (PTMC) Procedure: Step-by-Step Guide

PTMC is the recommended first-line therapy for symptomatic patients with severe mitral stenosis (valve area ≤1.5 cm²) who have favorable valve morphology without left atrial thrombus or moderate-to-severe mitral regurgitation. 1

Patient Selection Criteria

Before proceeding with PTMC, proper patient selection is crucial:

Ideal Candidates:

  • Symptomatic patients with severe MS (valve area ≤1.5 cm²)
  • Favorable valve morphology (Wilkins score ≤8)
  • Absence of left atrial thrombus
  • No moderate-to-severe mitral regurgitation
  • Mobile, relatively thin valve leaflets free of calcium
  • Minimal subvalvular disease

Contraindications:

  • Left atrial thrombus (absolute contraindication)
  • Moderate to severe mitral regurgitation (grade 3-4)
  • Severe or bicommissural calcification
  • Absence of commissural fusion
  • Severe concomitant valvular disease

Pre-Procedural Evaluation

  • Comprehensive echocardiography to assess:
    • Mitral valve area and gradient
    • Valve morphology and mobility
    • Commissural fusion pattern
    • Subvalvular apparatus
    • Pulmonary artery pressure
  • Transesophageal echocardiography to rule out left atrial thrombus
  • Assessment of mitral regurgitation severity

PTMC Procedure Steps

1. Patient Preparation

  • Administer local anesthesia at access site
  • Establish venous access via right femoral vein
  • Administer prophylactic antibiotics
  • Continuous hemodynamic monitoring

2. Right Heart Catheterization

  • Insert a pigtail catheter into the right femoral artery for pressure monitoring
  • Perform baseline hemodynamic measurements
  • Record baseline mitral valve gradient

3. Transseptal Puncture

  • Advance a Brockenbrough needle through a transseptal sheath to the fossa ovalis
  • Perform transseptal puncture under fluoroscopic guidance
  • Confirm left atrial position by pressure measurement and contrast injection
  • Administer heparin after successful left atrial entry

4. Left Atrial Access and Measurements

  • Advance the transseptal sheath into the left atrium
  • Measure left atrial pressure
  • Perform left atrial angiography if needed

5. Balloon Selection and Preparation

  • Select appropriate balloon size based on patient's height
  • For Inoue balloon technique (most commonly used):
    • Prepare the balloon catheter according to manufacturer's instructions
    • Test balloon inflation outside the body
    • Deflate completely before insertion

6. Crossing the Mitral Valve

  • Advance a guidewire from the left atrium into the left ventricle
  • In difficult cases with critical stenosis, use an AR-1 diagnostic catheter to facilitate left ventricular entry 2
  • For very difficult cases, exchange for a stiffer guidewire with small pre-formed loops at the tip

7. Balloon Positioning and Inflation

  • Track the balloon catheter over the guidewire into the left ventricle
  • Position the balloon across the mitral valve
  • Partially inflate the distal portion of the balloon in the left ventricle
  • Pull back until resistance is felt at the mitral valve
  • Complete balloon inflation to dilate the valve commissures
  • For Inoue technique, perform stepwise inflations at increasing balloon diameters

8. Assessment and Repeat Inflations

  • Measure transmitral gradient after each inflation
  • Assess for mitral regurgitation by left ventriculography or echocardiography
  • Continue with incremental balloon inflations until:
    • Adequate reduction in transmitral gradient is achieved
    • Mitral valve area increases to >1.5 cm²
    • Significant mitral regurgitation develops
    • Both commissures are split

9. Final Hemodynamic Assessment

  • Measure post-procedure mitral valve gradient
  • Calculate final mitral valve area
  • Assess for complications:
    • Mitral regurgitation (most common complication, occurs in ~8.4% of cases) 3
    • Left-to-right atrial shunt
    • Cardiac tamponade
    • Systemic embolism

10. Removal and Closure

  • Remove all catheters and sheaths
  • Achieve hemostasis at access sites
  • Apply pressure dressing

Post-Procedure Management

  • Monitor for complications for at least 24 hours
  • Perform echocardiography within 24 hours to assess:
    • Final mitral valve area
    • Presence and severity of mitral regurgitation
    • Left-to-right shunting across the atrial septum
  • Resume anticoagulation if indicated

Potential Complications and Management

  • Severe mitral regurgitation (3.3%): May require urgent mitral valve replacement if caused by leaflet rupture 3
  • Cardiac tamponade: Immediate pericardiocentesis
  • Systemic embolism: Urgent neurological evaluation and appropriate management
  • Atrial septal defect: Usually small and clinically insignificant; monitor for shunt

Procedural Success Indicators

  • Increase in mitral valve area to >1.5 cm²
  • Reduction in mean transmitral gradient
  • Decrease in left atrial pressure
  • Improvement in pulmonary artery pressure
  • No significant increase in mitral regurgitation

Special Considerations

  • In patients with left atrial appendage thrombus, PTMC may be considered after 2-3 months of adequate anticoagulation if repeat TEE shows thrombus resolution 4
  • The procedure should only be performed by experienced operators with immediate surgical backup available 1
  • Technical success rates exceed 90% in optimal candidates with complication rates below 3% 4

PTMC provides excellent immediate and long-term outcomes in properly selected patients, with sustained improvement in 80-90% of patients over 3-7 years 4, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Percutaneous Mitral Balloon Valvuloplasty Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Update on percutaneous mitral commissurotomy.

Heart (British Cardiac Society), 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.